New WHO Tools Address Gaps in Antimicrobial Resistance Testing
Posted on 18 Nov 2026
Antimicrobial resistance (AMR) is a growing global health threat, making infections increasingly difficult to diagnose and treat as they become resistant to standard antibiotics. Its spread is driven partly by antibiotic use in human healthcare, animal husbandry, and food production, contributing to infectious disease mortality worldwide. Despite the urgent need for effective prevention, accurate diagnostics, and responsible antibiotic use, new findings indicate that progress remains too slow to meet global targets.
The World Health Organization (WHO) has released two new tools intended to help countries strengthen diagnostic capacity for antimicrobial resistance. The first tool defines the tests that should be available across health care settings, from primary care centers to referral hospitals. The second compiles 73 laboratory procedures covering sample collection, pathogen identification and antibiotic susceptibility testing.

The tools were announced after a WHO investigation across 183 countries assessed progress in combating antimicrobial resistance. Nearly nine in 10 countries reported having a national action plan, compared with around four in 10 in 2017. However, only 42 countries reported having a plan that was financed, implemented and monitored.
Diagnostic access remains a major weakness in the response. Only 36% of countries had a national reference laboratory capable of testing for resistance in all bacteria and fungi monitored by WHO, compared with an 80% target for 2030. WHO also stated that 2023 global surveillance data showed one in every six laboratory-confirmed bacterial infections reported to the agency was resistant to antibiotics used for treatment. The agency estimated that antimicrobial resistance could cause about 39 million deaths between now and 2050.
“Antimicrobial resistance is widespread and threatening the future of modern medicine,” said Jean-Pierre Nyemazi, interim head of antimicrobial resistance at the WHO. “Unlike COVID-19, which was very visible, drug-resistant infections have been taking people's lives for years without us noticing it and raising the alarm as we should.”
“Countries are moving forward in every step, but progress still needs to be speeded up to reach the 2030 targets,” added Nyemazi.
Related Links
World Health Organization







.jpg)